Medscape

Targeted Therapy Nears EU Approval for Obstructive HCM

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...

'Avoidable' ambulance and hospital delays contributed to 21-month-old baby's death, coroner rules

Artemis 'Arty' Sanson died four hours after he became unwell and started having seizures at his home in Chatham, Kent on June ...

Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Final Decision from European Commission Expected in Q1 2026SOUTH SAN FRANCISCO, Calif., (GLOBE NEWSWIRE) -- Cytokinetics, ...

Cytokinetics, Incorporated: Cytokinetics Announces Positive CHMP Opinion of MYQORZO (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Final Decision from European Commission Expected in Q1 2026 SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Committee ...

Inquest concludes avoidable ambulance and hospital delays contributed to death of Chatham baby Artemis ‘Arty’ Sanson

An inquest has concluded into the death of a baby boy who died within four hours of becoming seriously unwell at his home.

Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...